Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep;17(5):851-4.
doi: 10.4103/2230-8210.117245.

Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism

Bindu Kulshreshtha  1 , Rajesh Khadgawat, Nandita Gupta, Ariachery Ammini
Affiliations

Progression of puberty after initiation of androgen therapy in patients with idiopathic hypogonadotropic hypogonadism

Bindu Kulshreshtha et al. Indian J Endocrinol Metab. 2013 Sep.

Abstract

Background: Onset of puberty in boys usually occurs by 14 years of age. Some boys may exhibit delayed sexual maturation till about 17-18 years of age. However, pubertal onset beyond 18 years of age is exceedingly rare.

Materials and methods: Patients diagnosed as idiopathic hypogonadotropic hypogonadism (IHH) who had onset of puberty (increase in testicular volume >10 ml) while on androgen therapy were studied. These patients were evaluated prospectively.

Results: There were nine subjects that were included in the study. The pre-therapy testicular volumes ranged from 3 to 6 ml. Luteinizing hormone (LH) levels increased from 1.2 ± 0.96 to 2.8 ± 1.0 IU/L, follicular stimulating hormone (FSH) levels increased from 1.5 ± 0.79 to 3.5 ± 1.9 IU/L, and testosterone increased from 0.36 ± 0.16 to 3.4 ± 2.1 ng/ml. Three out of nine patients had testosterone levels below 3 ng/ml.

Conclusion: Our present study indicates that pubertal development can occur in patients presenting with hypogonadotropic hypogonadism after 18 years of age. However, acquired pubertal status may be subnormal.

Keywords: Delayed puberty; progression of puberty; reversal of hypogonadotropic hypogonadism.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Pitteloud N, Hayes FJ, Boepple PA, DeCruz S, Seminara SB, MacLaughlin DT, et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002;87:152–60. - PubMed
    1. De Luca F, Argente J, Cavallo L, Crowne E, Delemarre-Van de Waal HA, De Sanctis C, et al. International Workshop on Management of Puberty for Optimum Auxological Results. Management of puberty in constitutional delay of growth and puberty. J Pediatr Endocrinol Metab. 2001;14(Suppl 2):953–7. - PubMed
    1. Styne DM. In: Puberty and its disorders. Vol. 20. Philadelphia: W.B. Suanders; 1991. Puberty and its disorder in Boys; p. 4371.
    1. Wilkins L, editor. The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence. 2nd ed. chapter 10. Springfield, Illinois: Thomas; 1957. Variations in the pattern of adolescent development.
    1. Raivio T, Falardeau J, Dwyer A, Quinton R, Hayes FJ, Hughes VA, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007;357:863–73. - PubMed